Literature DB >> 15486683

[HIV patients' understanding of information on antiretroviral therapy].

Maria das Graças Braga Ceccato1, Francisco A Acurcio, Palmira de Fátima Bonolo, Gustavo M Rocha, Mark D C Guimarães.   

Abstract

To assess the understanding of information related to antiretroviral therapy among HIV-infected patients enrolled in public AIDS services (Belo Horizonte, Minas Gerais State, Brazil), a cross-sectional analysis was carried out, based on interviews with patients after initial provision of antiretroviral drugs. The study evaluated the information on antiretroviral therapy provided by healthcare professionals and the patients' level of understanding in relation to prescription information. This level was classified as insufficient if there was disagreement of more than 30.0% between the information reported by the patient and the written prescription. Divergence between prescriptions and information reported by 358 interviewed patients was observed. The level of understanding regarding the prescribed antiretroviral was obtained, and 26.3% of patients displayed insufficient understanding. The results show an important proportion of patients with misunderstanding of information regarding antiretroviral therapy, mainly those with limited schooling and low income. It is necessary to bolster strategies to increase quality of recommendations provided to these patients. Improving the multidisciplinary team approach to patient care should help reverse the observed situation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486683     DOI: 10.1590/s0102-311x2004000500034

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  1 in total

1.  Association of outcomes with comprehension, adherence and behavioral characteristics of tuberculosis patients using fixed-dose combination therapy in Contagem, Minas Gerais, Brazil.

Authors:  Ana Maria Viegas; Silvana Spíndola de Miranda; João Paulo Haddad; Maria das Graças Ceccato; Wânia da Silva Carvalho
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-06-01       Impact factor: 1.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.